Cargando…
Future of the drug label: Perspectives from a multistakeholder dialogue
Regulating drugs does not end when market access has been granted. Monitoring drugs over the life cycle has become state of the art, inherent to evolving legislation and societal need. Here, we explore how the drug label could move along in a changing playing‐field and become a sustainable label for...
Autores principales: | Gispen‐de Wied, Christine C., Weemers, Just, Boon, Wouter, Mol, Peter G.M., Stolk, Pieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783599/ https://www.ncbi.nlm.nih.gov/pubmed/31317570 http://dx.doi.org/10.1111/bcp.14070 |
Ejemplares similares
-
Using multistakeholder dialogues to assess policies, programmes and progress for women’s, children’s and adolescents’ health
por: Frost, Laura, et al.
Publicado: (2016) -
Policy dialogue as a collaborative tool for multistakeholder health governance: a scoping study
por: Robert, Emilie, et al.
Publicado: (2020) -
A standardised framework to identify optimal animal models for efficacy assessment in drug development
por: S. Ferreira, Guilherme, et al.
Publicado: (2019) -
Drug Shortages From the Perspectives of Authorities and Pharmacy Practice in the Netherlands: An Observational Study
por: Postma, Doerine J., et al.
Publicado: (2018) -
Correction: A standardised framework to identify optimal animal models for efficacy assessment in drug development
por: Ferreira, Guilherme S., et al.
Publicado: (2019)